Per-operative COVID-19 modifications for oculoplastic service: patients perspective and regional review of practice of a protective draping technique.

PURPOSE: COVID-19 has posed problems for oculoplastic surgeons. One issue we felt needed to be addressed was the way patients are draped for surgery. Traditionally patients are draped with their full face exposed, and as a result, aerosols generated from both the patient and surgical team put the other party at risk. METHODS: We created a new draping technique which would create a physical barrier. A regional survey was undertaken to compare regional oculoplastic draping practices with our practice locally in light of the COVID-19 pandemic. A patient satisfaction survey was also completed to understand the impact of our change in practice. RESULTS: Our regional survey generated 22 consultant responses. 36% (8) continued with their normal practice with the full face exposed. 18% (4) of the responders had modified a cataract drape and 45% (10) used a bespoke drape with or without a mask. We started using this modified drape in June 2020 and in the patient survey, 100 percent of patients felt the drape was comfortable and 30% of the patients commented on the relief that they did not have to wear a face mask during surgery. CONCLUSIONS: Our draping technique provides an alternative to the traditional full face exposure draping. It is simple, inexpensive, and readily available. It also addresses and resolves the issue of safety of the oculoplastic surgeon and surgical team whilst maintaining comfort for the patient throughout, particularly when risks the of COVID are ongoing and with the potential of more viruses in the future.

The impact of COVID-19 on the progression and management of periocular basal cell carcinomas.

PURPOSE: To identify whether the delay caused by COVID-19 had an impact on the peroperative size of lesions and the choice of reconstruction performed in patients with periocular basal cell carcinomas (BCCs). METHODS: We undertook a retrospective study looking at whether the delay caused by COVID-19 had an impact on the lesion size at the time of surgery, and consequently, on the choice of surgical repair. Results were compared to an equivalent time period a year prior to the onset of COVID-19. Elective surgery was stepped down at our hospital between March and June 2020. We collected data on patients that underwent BCC excisions between July 2020 and April 2021 and for an equivalent time period from 2019 to 2020. Measurements at listing were compared with those preoperatively obtained and from histological specimen. RESULTS: Analysis using the paired T-test yielded a p-value 0.005 for the growth of the lesion between listing and surgery after the onset of the pandemic, while pre-COVID the p-value was 0.04. Most patients were able to undergo the same procedure as planned for despite the delay and statistically significant growth while awaiting surgery. CONCLUSION: Literature suggests that BCC operations can be safely delayed up to 3 months. Our longest wait post-COVID was 12 months with a mean wait of 5 months. Only two patients in this group had a more invasive surgery than planned. We conclude that the delay caused by the pandemic, even beyond 3 months, had a minimal impact on the surgical plan and outcomes for patients with BCCs.